These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
33. The interstitial lung disease multidisciplinary meeting: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia. Prasad JD; Mahar A; Bleasel J; Ellis SJ; Chambers DC; Lake F; Hopkins PMA; Corte TJ; Allan H; Glaspole IN Respirology; 2017 Oct; 22(7):1459-1472. PubMed ID: 28891101 [TBL] [Abstract][Full Text] [Related]
35. Effects of patient satisfaction and confidence on the success of treatment of combined rheumatic disease and interstitial lung disease in a multidisciplinary outpatient clinic. Jeong SO; Uh ST; Park S; Kim HS Int J Rheum Dis; 2018 Aug; 21(8):1600-1608. PubMed ID: 30146740 [TBL] [Abstract][Full Text] [Related]
36. Interstitial lung diseases: an observational study in patients admitted in "Marius Nasta" Institute of Pulmonology Bucharest, Romania, in 2011. Strâmbu I; Belaconi I; Stoicescu I; Ioniţă D; Cojocaru F; Niţă C; Dospinoiu D; Bumbăcea R Pneumologia; 2013; 62(4):206-11. PubMed ID: 24734353 [TBL] [Abstract][Full Text] [Related]
37. Classification and natural history of the idiopathic interstitial pneumonias. Kim DS; Collard HR; King TE Proc Am Thorac Soc; 2006 Jun; 3(4):285-92. PubMed ID: 16738191 [TBL] [Abstract][Full Text] [Related]
38. Interstitial lung diseases--where we started from and are now going. Reynolds HY; Gail DB; Kiley JP Sarcoidosis Vasc Diffuse Lung Dis; 2005 Mar; 22(1):5-12. PubMed ID: 15881274 [TBL] [Abstract][Full Text] [Related]
39. Biomarkers to identify ILD and predict lung function decline in scleroderma lung disease or idiopathic pulmonary fibrosis. Kennedy B; Branagan P; Moloney F; Haroon M; O'Connell OJ; O'Connor TM; O'Regan K; Harney S; Henry MT Sarcoidosis Vasc Diffuse Lung Dis; 2015 Sep; 32(3):228-36. PubMed ID: 26422568 [TBL] [Abstract][Full Text] [Related]